Saluda Medical Announces Presentation of New Clinical Data at the 2025 NANS Annual Meeting

Presentations Included First Human Data on EVA™, Saluda's Automated SCS Programming Platform MINNEAPOLIS, Feb. 5, 2025 /PRNewswire/ -- Saluda Medical, Inc., a pioneer in the development and commercialization of a novel neuromodulation platform designed to transform the lives of patients...